Sclerostin: More than a bone formation brake.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27089203.
- Also identified by DOI 10.1126/scitranslmed.aaf4628.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anti-sclerostin treatment spurs an unexpected acceleration of bone erosion in a mouse model of rheumatoid arthritis (Wehmeyeret al, this issue).
Medical subject headings
- Bone Morphogenetic Proteins
- Osteogenesis